Condition
Telangiectases
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Peterio
Related Conditions
Often studied with 4 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown2
Clinical Trials (2)
Research Network
Common Treatments
- Peterio1
- Ipl Quantum Product Manufactured By Luminis Ltd1
Active Sponsors
- Rambam Health Care Campus1
- Scilex Ltd.1
- Lumenis Be Ltd.1
Top Investigators
Plastic Surgery Dept., Rambam Medical Center., Haifa,Israel
Hadassah Medical Center, Dermatology
Related Conditions
- Hirsutism1
- Hypertrichosis1
- Rhytides1
- Port Wine Stain1